Literature DB >> 11745198

The intratumoral expression of vascular endothelial growth factor and interleukin-8 associated with angiogenesis in nonsmall cell lung carcinoma patients.

D Masuya1, C Huang, D Liu, K Kameyama, E Hayashi, A Yamauchi, S Kobayashi, R Haba, H Yokomise.   

Abstract

BACKGROUND: Angiogenesis has important effects on tumor growth and metastasis. It is regulated by a variety of angiogenic and angiostatic factors.
METHODS: To evaluate the effects of tumor cell-derived angiogenic factors, we performed an immunohistochemic study to evaluate the intratumoral expression of vascular endothelial growth factor (VEGF) and interleukin-8 (IL-8) in relation to intratumoral microvessel density (IMD) in tumors from 104 nonsmall cell lung carcinoma (NSCLC)patients.
RESULTS: Fifty-four carcinomas were VEGF-positive, 47 carcinomas were IL-8-positive, and 53 carcinomas were hypervascular tumors. There was no significant correlation between the percentages of positive VEGF-staining and positive IL-8-staining in NSCLCs (rho = 0.174, P = 0.080). The IMD of VEGF-positive carcinomas was significantly greater than that of VEGF-negative carcinomas (P = 0.023). In addition, the IMD of IL-8-positive carcinomas was significantly greater than that of IL-8-negative carcinomas (P =0.013). The overall survival rate of patients with hypervascular tumors was significantly lower than that of patients with hypovascular tumors (41.0% versus 67.0%, P = 0.004). Cox proportional-hazards regression model also demonstrated that angiogenesis was one of the significant factors in predicting the survival of NSCLC patients (relative risk = 1.944, P = 0.041).
CONCLUSIONS: Intratumoral expression of VEGF and IL-8 was associated with angiogenesis in NSCLCs. Tumor angiogenesis significantly affected the prognosis of NSCLC patients. Copyright 2001 American Cancer Society.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11745198     DOI: 10.1002/1097-0142(20011115)92:10<2628::aid-cncr1616>3.0.co;2-f

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  38 in total

1.  DJ-1 enhances cell survival through the binding of Cezanne, a negative regulator of NF-kappaB.

Authors:  R Sean McNally; Beckley K Davis; Casey M Clements; Mary Ann Accavitti-Loper; Tak W Mak; Jenny P-Y Ting
Journal:  J Biol Chem       Date:  2010-11-19       Impact factor: 5.157

2.  Identification of the dominant angiogenic CXCL class chemokines associated with non-small cell lung cancer via bioinformatics tools.

Authors:  Nese Unver
Journal:  Med Oncol       Date:  2021-05-13       Impact factor: 3.064

3.  3D culture broadly regulates tumor cell hypoxia response and angiogenesis via pro-inflammatory pathways.

Authors:  Peter DelNero; Maureen Lane; Scott S Verbridge; Brian Kwee; Pouneh Kermani; Barbara Hempstead; Abraham Stroock; Claudia Fischbach
Journal:  Biomaterials       Date:  2015-04-13       Impact factor: 12.479

4.  Biological interaction of cigarette smoking on the association between genetic polymorphisms involved in inflammation and the risk of lung cancer: A case-control study in Japan.

Authors:  Yuzo Yamamoto; Chikako Kiyohara; Saiko Suetsugu-Ogata; Naoki Hamada; Yoichi Nakanishi
Journal:  Oncol Lett       Date:  2017-03-17       Impact factor: 2.967

5.  Diversity of the angiogenic phenotype in non-small cell lung cancer.

Authors:  Marc R McClelland; Shannon L Carskadon; Liujian Zhao; Eric S White; David G Beer; Mark B Orringer; Allan Pickens; Andrew C Chang; Douglas A Arenberg
Journal:  Am J Respir Cell Mol Biol       Date:  2006-11-01       Impact factor: 6.914

6.  No association of vascular endothelial growth factor-A (VEGF-A) and VEGF-C expression with survival in patients with gastric cancer.

Authors:  Soo Jung Lee; Jong Gwang Kim; Sang Kyun Sohn; Yee Soo Chae; Joon Ho Moon; Shi Nae Kim; Han-Ik Bae; Ho Young Chung; Wansik Yu
Journal:  Cancer Res Treat       Date:  2009-12-31       Impact factor: 4.679

7.  Chemokine receptor expression in tumour islets and stroma in non-small cell lung cancer.

Authors:  Chandra M Ohri; Aarti Shikotra; Ruth H Green; David A Waller; Peter Bradding
Journal:  BMC Cancer       Date:  2010-04-29       Impact factor: 4.430

8.  Transactivation of vascular endothelial growth factor receptor-2 by interleukin-8 (IL-8/CXCL8) is required for IL-8/CXCL8-induced endothelial permeability.

Authors:  Melissa L Petreaca; Min Yao; Yan Liu; Kathryn Defea; Manuela Martins-Green
Journal:  Mol Biol Cell       Date:  2007-10-10       Impact factor: 4.138

9.  Mechanisms underlying differential expression of interleukin-8 in breast cancer cells.

Authors:  Ariane Freund; Valérie Jolivel; Sébastien Durand; Nathalie Kersual; Dany Chalbos; Carine Chavey; Françoise Vignon; Gwendal Lazennec
Journal:  Oncogene       Date:  2004-08-12       Impact factor: 9.867

10.  Serum concentrations of cytokines and lung cancer survival in African Americans and Caucasians.

Authors:  Lindsey Enewold; Leah E Mechanic; Elise D Bowman; Yun-Ling Zheng; Zhipeng Yu; Glenwood Trivers; Anthony J Alberg; Curtis C Harris
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-01       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.